Vimarsana
Biggest News Aggregation in the World

Athira Pharma Chart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Athira Pharma Chart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Athira Pharma Chart Today - Breaking & Trending Today

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease Seite 1 - Vimarsana News

Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease Seite 1

03.01.2024 - Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation and potential clinically meaningful activity of fosgonimeton Potential first-in-class approach ... Seite 1

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton's Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer's Disease Seite 1 - Vimarsana News

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton's Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and Neuroinflammation in Models of Alzheimer's Disease Seite 1

15.11.2023 - Data presented at Society for Neuroscience Annual Meeting 2023BOTHELL, Wash., Nov. 15, 2023 (GLOBE NEWSWIRE) - Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore ... Seite 1